echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Food News > Food Articles > Seven Chinese scholars were invited to join Cell's Academic Advisory Board

    Seven Chinese scholars were invited to join Cell's Academic Advisory Board

    • Last Update: 2021-03-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    recently, china Science Daily noted that the official website of Cell Press had updated the list of academic advisers to cell magazines
    meetings.
    , Gao
    , Wang Hongwei, Huang Sanwen, Gao Caixia, Chen Lingling, Zhang
    and seven other Chinese scientists were selected. Together with Cao Xuetao and Deng Hongkui, who were selected in 2013, cell
    has nine Chinese scholars. At present, there
    119 members of the Council.
    is recognized as the world's leading journal in the field of life sciences, since its inception in 1974 has nearly 46 years of history.
    it is understood that cell academic
    will take the invitation system. John Pham, editor-in-chief of the magazine, replied to the China Science Journal, "These invited scientists are respected by us and have made great contributions to the scientific community and to our journals." From time
    , members of the Academic Advisors Association will provide guidance or constructive advice on editorial decisions and the direction of journal development, including recommendations on editorial policies and new plans. They are our window into close contact with all disciplines.
    Pham said the members of the Academic Advisors
    association had no fixed term, but they planned to review their lists regularly to ensure that the overall balance of the members of the academic advisers
    council and their fit with the journal itself.
    it is understood that there are currently four Nobel laureates in cell's academic advisory
    meeting: Joe Goldstein, winner of the 1985 Nobel Prize in Physiology or Medicine, 2012 Nobel Laureate in Physiology or Medicine Shinya Yamanaka, 2012 Nobel Laureate in Chemistry Brian Kobilka, and 2018 Nobel Laureate in Physiology or Medicine Jim Allison.
    China Science Daily also learned from Cell Press that there are more journals that will be adjusted and expanded in the near future by the academic consultant
    . This is actually the publisher's overall strategy for fulfilling its commitment to diversity, particularly in advancing gender diversity.
    the newly selected Chinese scholars included two female scientists.Deborah Sweet, vice president of editorial at
    Cell Press, said, "By the end of 2020,
    , an academic consultant in cell publishing houses' research and review journals, will expand its female membership to 30 percent, and our goal is that
    , an academic consultant in all journals, will have half of the female membership." , Third World
    , U.S.
    , European Molecular Biology Organization foreign
    , American Association for the Promotion of Science. He is currently the Director of the China Center for Disease Control and Prevention, the Deputy Director of the
    National Natural Science Foundation of China, and the Director of the Key Laboratory of
    Pathogenic Microbiology and Immunology in China. The main research areas are cystic membrane virus and structural immunology, focusing on new and re-emerging infectious diseases represented by influenza.stem cells and developmental biologists,
    . He is currently
    -Secretary-General of the
    the Institute of Zoology and Technology. Mainly engaged in reproduction, development, stem cells and other research and transformation work. He has long served as chief scientist of the National "973" Program, the "863" Program, and the National Major Scientific Research Program, and the Chief Scientist of the
    Stem Cell and Regenerative Medicine Research, Organ Reconstruction and Manufacturing Strategic Science and Technology Pilot Project (Category A).a structural biologist and is currently a professor at Tsinghua University'
    School of Life Sciences and the Tsinghua-Peking University Joint Center for Life Sciences PI. In September 2019, he was awarded the Science Discovery Award. The main research areas include: more efficient and higher resolution methodological development of cryoelectric mirrors, coordination mechanisms of cytosomes and biofilm systems, molecular mechanisms and regulation of nucleic acid quality control.is currently the Director of the
    Agricultural Genomics Research Institute of The Chinese Academy of Agriculture. He has been awarded the second prize of the National Natural Science Award, the "Science and Technological Progress Award" of the He Liang Heli Foundation and the "Basic Science Award" of the Zhou Guangchao Foundation. Focusing on vegetable crops, we are committed to using histological big data to advance the frontiers of plant biology and drive crop breeding change. He has presided over the mapping of various vegetable genome sequences and is one of the founders of the international vegetable genome research field.Researcher, National Key Laboratory for Plant Cell and Chromosomal Engineering, Institute of Genetics and Developmental Biology. Mainly engaged in plant genome editing technology, biosecurity new breeding technology and genome editing directional design molecular breeding research, is committed to promoting the application of genome editing in molecular design breeding.Researcher, Shanghai Institute of Life Sciences. He has been awarded the Life Sciences Innovation Award, the CBIS Distinguished Young Researcher Award of the Global Chinese Biologists Association, and the China Young Women Scientist Award. The main research areas are long non-coding RNA and stem cells, functional regulation of lncRNAs in mammalian cells, etc., a professor at Peking University's School of Life Sciences, is dedicated to the discovery of cancer drug targets and biomarkers using high-tech such as machine learning and high-volume sequencing. Led the world's first tumor genome sequencing, in the current clinical trials of a number of cancer treatment drugs in the molecular target of the original discovery made a direct contribution.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.